For example, OPKO Health’s 4Kscore test integrates measured values of four prostate-specific kallikrein proteins (intact PSA, free PSA, total PSA and human Kallikrein-2), also considering the clinical data of the patient in order to calculate a personalized risk for aggressive prostate cancer [52,53]. This evidence concerns the gene KLK4 and prostate cancer.